Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
The U.S. Health Department launched Ready, Set, PrEP to provide the HIV prevention med at no cost.
This will provide free PrEP to as many as 200,000 uninsured Americans until 2030.
A look at the supply chain that results in very high costs for HIV and hepatitis C medications.
Here’s how each undergraduate student plans to fight the HIV epidemic.
With funding by the three coordinating centers of the Gilead COMPASS Initiative
Located at the Rush Center, the SPOT builds upon the knowledge of people living with HIV.
Three “high-profile advocates” share candid tales as part of Gilead’s video series to prevent HIV and STIs.
Madrigal Pharmaceuticals is the latest company to enter into what’s becoming a crowded market.
These interventions are part of the Southern AIDS Coalition’s COMPASS partnerships.
The government pays the maker of Truvada about 75 cents a pill; the same dose costs about $50 in the United States.
The triple-drug combo would be the first once-daily, single-tablet regimen for those with all genotypes who’ve failed a previous treatment.
Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.